ASX:MSB

Email Alerts for:
ASX:MSB

Midday: Aus shares higher at noon

14 Feb 2014 - Qantas Airways Limited (ASX:QAN) budget off-shoot Jetstar has announces it will start code sharing with Emirates.

Midday: Aus shares flat, AUD drops on GDP

04 Dec 2013 - Aus shares flat, AUD drops on GDP. Mesoblast limited (ASX:MSB) shares are stronger after announcing top line results from Phase 2 trials of its proprietary Mesenchyma…

Midday: Aus shares flat at noon

26 Nov 2013 - Aus shares flat at noon. Mayne Pharma Group Limited (ASX:MYX) lifts revenues by 230 per cent to $45 million in the first four months of fiscal 2014, boosted by the ac…

Midday: ASX 0.25% down at noon

06 Nov 2013 - ASX 0.25% down at noon. Commonwealth Bank of Australia (ASX:CBA) shares hit another record in early trade, following the lender’s bumper first quarter profit of $2.1 …

Midday: NAB result drags down Big Four Banks

31 Oct 2013 - NAB result drags down Big Four Banks. Shares in Lynas Corporation Limited (ASX:LYC) rise after posting higher production and shipments in the September quarter.

Midday: ASX 0.4% up at noon

30 Oct 2013 - ASX 0.4% up at noon. Chairman James Packer tells investors that Crown’s initial $600 million investment in a Macau casino is now worth in excess of $6 billion.

Market Wrap: ASX shrugs off Obama rejection

11 Oct 2013 - ASX shrugs off Obama rejection. DEXUS Property Group (ASX:DXS) and the Canada Pension Plan Investment Board propose a $2.3 billion buy-out of Commonwealth Property Of…

Midday: ASX soars as US stalemate protracts

11 Oct 2013 - ASX soars as US stalemate protracts. Mesoblast Limited (ASX:MSB) shares jump after it announces the acquisition of the entire mesenchymal stem cell business of New Yo…

Midday: ASX pensive amid US impasse

01 Oct 2013 - ASX pensive amid US impasse. Maverick Drilling and Exploration Limited (ASX:MAD) acquires three additional workover rigs, currently being tooled for development at it…

Beware the 5300 peak

18 Sep 2013 - Investment advisor Gary Glover takes a technical look at S&P/ASX200, Dow Jones Industrials, FMG, AMM, SCP, MYR, COH, LEI, BKL, MSB, ECQ.

Midday: ASX slips on US stimulus speculation

18 Jul 2013 - ASX slips on US stimulus speculation. Aurizon Holdings Limited (ASX:AZJ) is trimming costs - flagging up to $230 million of cost savings over the next two years.

The opportunities keep on coming

10 Jul 2013 - Investment adviser Michael Gable takes a technical look at STO, DLS, AWE, MSB, ORG.

Market Wrap: ASX 1.6% up, all sectors higher

26 Jun 2013 - ASX 1.6% up, all sectors higher. Aquila Resources Limited (ASX:AQA) delays construction of its Eagle Downs coal project in Queensland due to continuing softness in th…

Midday: ASX takes off on US confidence

26 Jun 2013 - ASX takes off on US confidence. Paladin Energy Limited (ASX:PDN) delays the outcome of a strategic initiative regarding the sale of a minority equity position in its …

Chinese equities set to rise

05 Jun 2013 - Investment advisor Gary Glover takes a technical look at S&P/ASX 200, Dow Jones, CRB Index, Nikkei, Shanghai Composite, CBA, WBC, TOL, QBE, SLR, AWE, MSB, ELM & AZH.

Midday: ASX healthy at noon

22 Apr 2013 - ASX healthy at noon. Insurance Australia Group Limited (ASX:IAG) completes the sale of its major UK asset.

Market Wrap: ASX surges after Dow record

06 Mar 2013 - ASX surges after Dow record. Regenerative medicine company Mesoblast Limited (ASX:MSB) is set to raise $170 million to drive advanced programs.

Mesoblast granted new US & China patents

07 Feb 2013 - Mesoblast limited (ASX:MSB) is granted three new patents by the United States Patent and Trade Mark Office (USPTO) and the State Intellectual Property Office of China…

Midday: Aus shares hit fresh 21 month high

01 Feb 2013 - Aus shares hit fresh 21 month high. Virgin Australia Holdings Limited (ASX:VAH) welcomes shareholder approval of its proposed 60 per cent acquisition of Tiger Airways…

FDA clears Mesoblast Phase 2 clinical trial

31 Jan 2013 - Mesoblast Limited (ASX:MSB) receives regulatory clearance to start Phase 2 Clinical Trials on patients with active rheumatoid arthritis.

Market Wrap: ASX drops over day & week

11 Jan 2013 - ASX drops over day & week. National Australia Bank Limited (ASX:NAB) cuts its forecasts for Australian growth and predicts the RBA will cut rates by more than first e…

Midday: Aus shares pull back from open

11 Jan 2013 - Aus shares pull back from open. Mesoblast limited (ASX:MSB) will move into stage 3 trials of its stem cell treatment for back pain after early trials delivered positi…

Market Wrap: Aus shares close 0.7% higher

29 Nov 2012 - Aus shares close 0.7% higher. Dexus Property Group (ASX:DXS) has confirmed it is in negotiations to sell off the remainder of its US assets with a prospective buyer.

ASX approaching long term crossroad

15 Aug 2012 - Investment advisor Gary Glover takes a technical look at All Ords, Shanghai Composite, S&P 500, Consumer Discretionary, Telco Services, TLS, COH, CGF, CBA, JBH, LEI, …

Mesoblast targets rheumatoid arthritis

24 Jul 2012 - Mesoblast limited (ASX:MSB) has achieved positive results in its clinical trial of an intravenous injection designed to aid sufferers of rheumatoid arthritis.